MAPT and Alzheimer disease: In patients with mild cognitive impariment (MCI), levels of Aβ42 in cerebrospinal fluid (CSF) are decreased years before conversion to dementia, whereas tau and p-tau levels are later markers [1], suggesting that AD starts with Aβ pathogenesis whereas tau pathology may have a role in a later state in the disease.